Daniel Fulton

Daniel Fulton has a breadth of experience in the pharmaceutical and healthcare industries, spanning over 20 years. Daniel currently works at Intercept Pharmaceuticals as the Associate Director of IDN's Northeast region, where they have been recognized as the Associate Director of the Year for Key Accounts in 2022. In this role, they are responsible for establishing and maintaining relationships with key opinion leaders and driving rare disease partnerships with Integrated Delivery Networks in the Northeast United States. Daniel specializes in utilizing Electronic Medical Records and computer algorithmic pathways to improve early disease identification and enhance quality and outcomes improvements in rare liver diseases.

Prior to their current role, Daniel worked at Melinta Therapeutics as a Regional Sales Manager for three years. Before that, they served as a Regional Sales Director for Hyperimmunes at Grifols for one year. Daniel also gained valuable experience at Salix Pharmaceuticals, a division of Valeant Pharmaceuticals, where they held various roles such as Regional Sales Manager for Institutional Sales in the Mid Atlantic region and Eastern Regional Sales Manager for Rare Diseases. Daniel also served as a Sales Manager at the national level and as a Key Account Manager during their time at Salix Pharmaceuticals.

Daniel's work experience also includes roles at Cadence Pharmaceuticals as a Regional Account Manager, Pfizer (Wyeth) as a Hospital Account Manager and Sales Representative, and MURO Pharmaceuticals, Inc. as a Sales Representative. Daniel started their career at PricewaterhouseCoopers as a Senior Associate.

Throughout their career, Daniel has demonstrated a strong track record of sales and account management success, utilizing their expertise and knowledge in the pharmaceutical industry.

Daniel Fulton attended the University of Maryland - Robert H. Smith School of Business from 1994 to 1997, where they earned a Bachelor's Degree in Accounting.